Literature DB >> 1845975

Reduction of basic fibroblasts growth factor receptor is coupled with terminal differentiation of chondrocytes.

M Iwamoto1, A Shimazu, K Nakashima, F Suzuki, Y Kato.   

Abstract

Basic fibroblast growth factor (bFGF) stimulates proliferation of chondrocytes and their extracellular matrix synthesis but inhibits terminal differentiation to hypertrophic cells (Kato, Y., and Iwamoto, M., (1990) J. Biol. Chem. 265, 5903-5909). In the present study, we examined changes in bFGF binding during chondrocyte cytodifferentiation. In cultures of pelleted growth plate chondrocytes, binding of 125I-bFGF to 140-kDa receptors was observed during the mitotic and matrix-forming stages but decreased to a very low level as chondrocytes became hypertrophic. Scatchard plot analysis showed that the decrease in binding of bFGF was due to a decrease in the number not in the affinity of the receptor. The loss of bFGF receptor was associated with a decrease in biological responses to bFGF. On the other hand, the binding of transforming growth factor-beta and epidermal growth factor was constant throughout all stages of growth plate chondrocytes. A rapid decrease in bFGF binding was not observed with articular chondrocytes or bFGF-exposed growth plate chondrocytes, perhaps because they scarcely underwent terminal differentiation. A decrease in bFGF binding associated with terminal differentiation in situ was also demonstrated by examination of sequential slices of growth plates. These observations suggest that rapid reduction in bFGF receptor is a special event during terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845975

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  A rapid and ultrasensitive method for measurement of DNA, calcium and protein content, and alkaline phosphatase activity of chondrocyte cultures.

Authors:  C C Teixeira; M Hatori; P S Leboy; M Pacifici; I M Shapiro
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

Review 2.  Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.

Authors:  P J Verschure; C J Van Noorden; J Van Marle; W B Van den Berg
Journal:  Histochem J       Date:  1996-12

Review 3.  Skeletal development and osteoarthritis.

Authors:  C W Archer
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

4.  Transforming growth factor-beta2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production.

Authors:  Elena V Tchetina; John Antoniou; Michael Tanzer; David J Zukor; A Robin Poole
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

5.  Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management.

Authors:  Liesbeth Hameetman; Judith Vmg Bovée; Antonie Hm Taminiau; Herman M Kroon; Pancras Cw Hogendoorn
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

6.  Effects of interleukin-1 on syntheses of alkaline phosphatase, type X collagen, and 1,25-dihydroxyvitamin D3 receptor, and matrix calcification in rabbit chondrocyte cultures.

Authors:  Y Kato; K Nakashima; M Iwamoto; H Murakami; H Hiranuma; T Koike; F Suzuki; H Fuchihata; Y Ikehara; M Noshiro
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  An immunohistochemical study of basic fibroblast growth factor in the developing chick.

Authors:  Y Funakoshi; S Matsuda; K Uryu; H Fujita; N Okumura; M Sakanaka
Journal:  Anat Embryol (Berl)       Date:  1993-05

8.  Responsiveness of articular cartilage from normal and inflamed mouse knee joints to various growth factors.

Authors:  P J Verschure; L A Joosten; P M van der Kraan; W B Van den Berg
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

9.  Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.

Authors:  M K Webster; D J Donoghue
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

10.  Release of cell surface proteoglycans from differentiating colon cells proceeds by cleavage of lipophilic anchor peptides.

Authors:  J A McBain; G C Mueller
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.